Vaccine Nationalism Slows Down Distribution, Poonawalla Says

The transcript discusses the challenges faced by Kovacs in distributing vaccines globally, highlighting issues like vaccine nationalism and supply constraints. Despite agreements for millions of doses, equitable distribution remains difficult due to prioritization by manufacturers and raw materials nationalism. Funding, while significant, is not the primary issue; rather, it's the supply and manufacturing capacity. The goal of distributing two billion doses by year-end is challenging, with delays expected due to various factors, including national policies and manufacturing limitations.

What role do manufacturers play in the distribution of vaccines, according to the text?

Discuss the impact of vaccine nationalism on Kovacs' ability to distribute vaccines equitably.